BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27570154)

  • 1. Bench to bedside in appetite research: Lost in translation?
    Rodgers RJ
    Neurosci Biobehav Rev; 2017 May; 76(Pt A):163-173. PubMed ID: 27570154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of appetite suppression: implication for the treatment of obesity.
    Halford JC
    Curr Drug Targets; 2001 Dec; 2(4):353-70. PubMed ID: 11732637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite.
    Rodgers RJ; Holch P; Tallett AJ
    Pharmacol Biochem Behav; 2010 Nov; 97(1):3-14. PubMed ID: 20214921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological approaches for the treatment of obesity.
    Fernández-López JA; Remesar X; Foz M; Alemany M
    Drugs; 2002; 62(6):915-44. PubMed ID: 11929339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of appetite to treat obesity.
    Kim GW; Lin JE; Valentino MA; Colon-Gonzalez F; Waldman SA
    Expert Rev Clin Pharmacol; 2011 Mar; 4(2):243-59. PubMed ID: 21666781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New molecular targets in the pathophysiology of obesity and available treatment options under investigation.
    Valsamakis G; Lois K; Kumar S; Mastorakos G
    Clin Obes; 2014 Aug; 4(4):209-19. PubMed ID: 25826792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity: Current and potential pharmacotherapeutics and targets.
    Narayanaswami V; Dwoskin LP
    Pharmacol Ther; 2017 Feb; 170():116-147. PubMed ID: 27773782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug strategies for the treatment of obesity.
    Alemany M; Remesar X; Fernández-López JA
    IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of obesity: currently marketed and upcoming agents.
    Bays H; Dujovne C
    Am J Cardiovasc Drugs; 2002; 2(4):245-53. PubMed ID: 14727970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological management of appetite expression in obesity.
    Halford JC; Boyland EJ; Blundell JE; Kirkham TC; Harrold JA
    Nat Rev Endocrinol; 2010 May; 6(5):255-69. PubMed ID: 20234354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacotherapy of obesity].
    Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G
    Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Models and strategies in the development of antiobesity drugs.
    Agahi A; Murphy KG
    Vet Pathol; 2014 May; 51(3):695-706. PubMed ID: 23860008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pharmacotherapies for obesity poised to enter market.
    Jones D
    Nat Rev Drug Discov; 2009 Nov; 8(11):833-4. PubMed ID: 19876031
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy of obesity: emerging drugs and targets.
    Chakrabarti R
    Expert Opin Ther Targets; 2009 Feb; 13(2):195-207. PubMed ID: 19236237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of tesofensine on appetite sensations.
    Gilbert JA; Gasteyger C; Raben A; Meier DH; Astrup A; Sjödin A
    Obesity (Silver Spring); 2012 Mar; 20(3):553-61. PubMed ID: 21720440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of obesity: established and emerging therapies.
    Isidro ML; Cordido F
    Mini Rev Med Chem; 2009 Jun; 9(6):664-73. PubMed ID: 19519492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological review of Caralluma R.Br. with special reference to appetite suppression and anti-obesity.
    Dutt HC; Singh S; Avula B; Khan IA; Bedi YS
    J Med Food; 2012 Feb; 15(2):108-19. PubMed ID: 22191633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.
    Halford JC; Harrold JA; Boyland EJ; Lawton CL; Blundell JE
    Drugs; 2007; 67(1):27-55. PubMed ID: 17209663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons.
    Dietrich MO; Horvath TL
    Nat Rev Drug Discov; 2012 Sep; 11(9):675-91. PubMed ID: 22858652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.